Home diagnostic devices, telehealth close treatment gap for patients with AMD
Click Here to Manage Email Alerts
KOLOA, Hawaii — Self-operated home diagnostic devices together with digital health care providers can help close the care gap between office visits for patients with age-related macular degeneration, a speaker here said.
“Currently all of our treatments for wet AMD are based on patients coming in and getting their OCT done to decide whether they should be treated or not,” Judy E. Kim, MD, said at Retina 2023. “What if we can get more information at home on a day-to-day basis? How do they do? When do they convert? And, how do they do after they get an injection?”
Remote monitoring programs that use artificial intelligence-based technologies support the diagnosis of acute wet AMD conversion and can assist with monitoring wet AMD therapy between office visits, Kim said.
Further, preferential hyperacuity perimetry remote monitoring aids with choroidal neovascularization conversion detection at better visual acuity compared with standard of care office visits and self-reported symptoms, she said.
Home OCT-guided therapy may also be useful, she said, in that it opens the door for more personalized retreatment decisions based on fluid dynamics, which may allow for fewer days with fluid present throughout proactive treatment and giving physicians the ability to personalize clinic visits, particularly with regard to sustained release and longer-acting drugs.
“The future is exciting,” Kim said. “The marriage of telemedicine with artificial intelligence is exciting, and a lot more is ahead.”
Collapse
Kim JE. Update on home monitoring of AMD. Presented at: Retina 2023; Jan. 15-20, 2023; Koloa, Hawaii.
Read more about
Click Here to Manage Email Alerts